Therapeutic Targets of the TNF Superfamily

Editors:

ISBN: 978-0-387-89519-2 (Print) 978-0-387-89520-8 (Online)

Table of contents (15 chapters)

  1. Front Matter

    Pages i-xvii

  2. No Access

    Book Chapter

    Pages 1-7

    Overview of TNF Superfamily: A Chest Full of Potential Therapeutic Targets

  3. No Access

    Book Chapter

    Pages 8-36

    Therapeutic Interventions Targeting CD40L (CD154) and CD40: The Opportunities and Challenges

  4. No Access

    Book Chapter

    Pages 37-51

    Targeting TNF for Treatment of Cancer and Autoimmunity

  5. No Access

    Book Chapter

    Pages 52-63

    Targeting of BAFF and APRIL for Autoimmunity and Oncology

  6. No Access

    Book Chapter

    Pages 64-93

    The Role of FasL and Fas in Health and Disease

  7. No Access

    Book Chapter

    Pages 94-107

    OX40 (CD134) and OX40L

  8. No Access

    Book Chapter

    Pages 108-119

    Targeting CD70 for Human Therapeutic Use

  9. No Access

    Book Chapter

    Pages 120-129

    4-1BB as a Therapeutic Target for Human Disease

  10. No Access

    Book Chapter

    Pages 130-145

    RANK(L) as a Key Target for Controlling Bone Loss

  11. No Access

    Book Chapter

    Pages 146-155

    Targeting the LIGHT-HVEM Pathway

  12. No Access

    Book Chapter

    Pages 156-173

    GITR: A Modulator of Immune Response and Inflammation

  13. No Access

    Book Chapter

    Pages 174-185

    Targeting CD30/CD30L in Oncology and Autoimmune and Inflammatory Diseases

  14. No Access

    Book Chapter

    Pages 186-194

    Tumor Necrosis Factor Receptor Superfamily Member 21: TNFR-Related Death Receptor-6, DR6

  15. No Access

    Book Chapter

    Pages 195-206

    TRAIL and Other TRAIL Receptor Agonists as Novel Cancer Therapeutics

  16. No Access

    Book Chapter

    Pages 207-215

    Therapeutic Potential of VEGI/TL1A in Autoimmunity and Cancer

  17. Back Matter

    Pages 217-220